Autoinflammatory Diseases: An Update of Clinical and Genetic Aspects

Q. Yao; D. E. Furst

Disclosures

Rheumatology. 2008;47(7):946-951. 

In This Article

Abstract and Introduction

To review clinical manifestations and genetic features of the autoinflammatory diseases, a group of rare, genetically defined diseases which have been newly grouped into a coherent whole. We performed a literature review using the keywords ‘periodic fever syndrome’, ‘autoinflammatory disease’ and ‘therapy’. All relevant original and review articles in English were reviewed. A case report of each autoinflammatory disease was excerpted from the literature and presented. This review summarizes the clinical manifestations, genetic analysis and therapy of FMF, TNF-α receptor-associated periodic fever syndrome, hyperimmunoglobulinaemia D periodic fever syndrome and cryopyrin-associated periodic fever syndrome. These diseases have periodic fever, are hereditary and recurrent, with elevated acute-phase reactants. Differentiating features of these disorders are tabulated. Autoinflammatory diseases have some communalities in their presentation although they represent a relatively diverse group of genetically associated diseases.

Autoinflammatory diseases (AIDs), also called periodic fever syndrome, refer to a group of rare hereditary recurrent unprovoked inflammation without high titres of autoantibodies or antigen-specific T lymphocyte in the absence of infection.[1] These diseases primarily include FMF, TNF receptor-associated periodic fever syndrome (TRAPS), hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS), and the cryopyrin-associated periodic syndrome (CAPS) including familial cold autoinflammatory syndrome (FCAS), Muckle–Wells syndrome (MWS) and neonatal onset multi-system inflammatory disease (NOMID)/chronic infantile neurological cutaneous and articular syndrome (CINCA).

A case of each AID will be presented and followed by a review focusing on the clinical manifestations, genetic analysis, pathogenesis, complication and therapy of these diseases.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....